MATTHEW WIESE: Open Payments
NPI 1124035910 · RENO, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$304 in 6 payments from 5 companies in 2025. Trend: 2023 $413 · 2024 $22 · 2025 $304
Food & beverage: $304
| Company | Payments | Amount |
|---|---|---|
| BridgeBio Pharma, Inc. | 1 | $138 |
| Novo Nordisk Inc | 1 | $97 |
| Exact Sciences Corporation | 2 | $31 |
| Gilead Sciences, Inc. | 1 | $22 |
| Lilly USA, LLC | 1 | $15 |
Products named: Attruby, Ozempic, Cologuard Collection Kit, MOUNJARO.
Industry payments across NV — which companies pay providers there.
